CONMED

CNMD • NYSE •
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $311,632 $327,045 $304,578 $317,652
Gross Profit 161,978 184,329 168,059 170,690
EBITDA 54,933 60,973 30,300 27,418
EBIT 42,287 42,971 12,427 9,353
Net Income 19,709 33,071 15,837 13,732
Net Change In Cash 311,632 327,045 304,578 317,652
Cost of Revenue 1,357
Free Cash Flow 27,086 51,540 40,733 22,144
Cash 33,855 24,296 30,502 27,848
Basic Shares 31,272 31,502 31,689 31,795

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $1,240,954 $1,045,472 $1,010,635 $862,459
Gross Profit 643,067 571,245 568,036 460,300
EBITDA 182,186 -41,957 108,590 45,655
EBIT 130,786 70,054 37,847 -26,970
Net Income 64,459 -80,582 62,542 9,517
Net Change In Cash 1,240,954 1,045,472 1,010,635 862,459
Cost of Revenue 8,836 -6,509 1,500
Free Cash Flow 106,316 11,580 96,904 51,518
Cash 24,296 28,942 20,847 27,356
Basic Shares 31,548 30,040 32,216 29,464

Earnings Calls

Quarter EPS
2024-03-31 $0.79
2023-12-31 $1.06
2023-09-30 $0.90
2023-06-30 $0.83